Trexquant Investment LP
- SEC CIK
- 0001633445
- Latest filing
- Aug 14, 2026
GLUE holding history
Monte Rosa Therapeutics, Inc. in every 13F filed by Trexquant Investment LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GLUE overviewAll 13F holders of GLUEFull Q2 2026 holdings
- Shares (Q2 2026)
- 115,363
- Value
- $2.79M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 115,363 | $2.79M | <0.1% | +66,184+134.6% | Added | Holders |
| Q1 2026 | 49,179 | $809.0K | <0.1% | −100,533−67.2% | Reduced | Holders |
| Q4 2025 | 149,712 | $2.35M | <0.1% | +149,712 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −26,188−100.0% | Sold out | Holders |
| Q1 2025 | 26,188 | $121.5K | <0.1% | +26,188 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −25,657−100.0% | Sold out | Holders |
| Q3 2023 | 25,657 | $122.9K | <0.1% | +10,935+74.3% | Added | Holders |
| Q2 2023 | 14,722 | $100.8K | <0.1% | −7,003−32.2% | Reduced | Holders |
| Q1 2023 | 21,725 | $169.2K | <0.1% | +4,791+28.3% | Added | Holders |
| Q4 2022 | 16,934 | $128.9K | <0.1% | −24,666−59.3% | Reduced | Holders |
| Q3 2022 | 41,600 | $340.0K | <0.1% | +41,600 | New | Holders |